Key result
Postoperative day 1 procalcitonin diagnoses pneumonia after off-pump CABG with ~0.81 AUC.
Why the study?
Early postoperative pneumonia is relatively common after off-pump CABG, but traditional diagnosis remains difficult and few data exist regarding the early diagnostic value of procalcitonin.
Does serum procalcitonin on postoperative day 1 improve the early diagnosis of postoperative pneumonia compared to traditional diagnostic markers in patients undergoing off-pump coronary artery bypass grafting?
Cohort (n=402)
No
Does serum procalcitonin on postoperative day 1 improve the early diagnosis of postoperative pneumonia compared to traditional diagnostic markers in patients undergoing off-pump coronary artery bypass grafting?
Serum procalcitonin measured on postoperative day 1 provides superior diagnostic accuracy and clinical net benefit over traditional markers for identifying early postoperative pneumonia after off-pump CABG, particularly in patients presenting with SIRS.
Answers are grounded in this paper and cite their sources.
May aid EPOP diagnosis after off-pump CABG; leaves open whether prospective validation changes management.
BACKGROUND The incidence of early postoperative pneumonia (EPOP) after off-pump coronary artery bypass grafting surgery (CABG) is relatively high, but its diagnosis by traditional methods remains difficult, which could be deleterious to the prognosis. Moreover, few data exist regarding procalcitonin (PCT) in early diagnosis of pneumonia after off-pump CABG. Thus, this study was performed to evaluate the value of PCT in diagnosing EPOP after off-pump CABG. MATERIAL AND METHODS A total of 402 consecutive patients undergoing off-pump CABG were retrospectively enrolled. Forty-four patients were diagnosed with EPOP and 112 patients were diagnosed with systemic inflammatory response syndrome (SIRS). Chest roentgenogram, serum PCT, white blood cells, neutral granulocyte ratio, and daily maximum body temperature were recorded. The ability of PCT to diagnose EPOP was evaluated by receiver operating characteristic (ROC) analyses in comparison with traditional methods. Clinical net benefits were estimated via decision curve analysis (DCA). RESULTS PCT presented satisfying accuracy in diagnosing EPOP with a cutoff value of 1.585 ng/mL (area under the curve [AUC] 0.808, 95% confidence interval [CI] 0.724-0.891, sensitivity 73%, specificity 86%). PCT performed better in diagnosing EPOP among SIRS patients (AUC 0.868, 95% CI 0.748-0.988, sensitivity 85%, specificity 89%). DCA showed valuable clinical net benefits of PCT in diagnosing EPOP after off-pump CABG regardless of threshold selected. CONCLUSIONS PCT could be a diagnostic marker for EPOP after off-pump CABG. The optimal cutoff value for diagnosing EPOP was 1.585 ng/mL. The application of PCT in diagnosing EPOP in SIRS patients was also satisfying with a cutoff value of 1.775 ng/mL.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) conducted a cohort in Early postoperative pneumonia (EPOP) after off-pump coronary artery bypass grafting surgery (CABG) (n=402). Serum procalcitonin (PCT) level on postoperative day 1 vs. Traditional diagnostic methods (chest roentgenogram, white blood cells, neutral granulocyte ratio, and daily maximum body temperature) was evaluated on Diagnostic accuracy for early postoperative pneumonia (EPOP) within 3 days after off-pump CABG (AUC 0.808, 95% CI 0.724-0.891). Serum procalcitonin on postoperative day 1 diagnosed early postoperative pneumonia after off-pump CABG with an AUC of 0.808, 73% sensitivity, and 86% specificity at a 1.585 ng/mL cutoff.
Synapse has enriched 10 related papers. Consider them for comparative context: